Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 2/2004

01-06-2004 | ORIGINAL

Frequency of silent myocardial ischemia in type 2 diabetic patients and the relation with poor glycemic control

Authors: M. Araz, Z. Celen, I. Akdemir, V. Okan

Published in: Acta Diabetologica | Issue 2/2004

Login to get access
Metadata
Title
Frequency of silent myocardial ischemia in type 2 diabetic patients and the relation with poor glycemic control
Authors
M. Araz
Z. Celen
I. Akdemir
V. Okan
Publication date
01-06-2004
Publisher
Springer-Verlag
Published in
Acta Diabetologica / Issue 2/2004
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-004-0142-2

Other articles of this Issue 2/2004

Acta Diabetologica 2/2004 Go to the issue

ORIGINAL

Association of hypertension with cluster of insulin resistance syndrome factors: the Chennai Urban Population Study (CUPS-12)

ORIGINAL

Is diabetes an independent risk factor for mortality after myocardial infarction? The ARIC (Atherosclerosis Risk in Communities) Surveillance Study

ORIGINAL

Severe hyperglycemia: a determinant factor for hypofiltration in alloxan diabetic rats

ORIGINAL

Motor activity during asymptomatic nocturnal hypoglycemia in adolescents with type 1 diabetes mellitus

ORIGINAL

Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study

ORIGINAL

Comparison of uptitration of gliclazide with the addition of rosiglitazone to gliclazide in patients with type 2 diabetes inadequately controlled on half-maximal doses of a sulphonylurea

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits